Promoter-distal RNA polymerase II binding discriminates active from inactive CCAAT/ enhancer-binding protein beta binding sites

Genome Research

Volumn 25, Issue 12, 2015, Pages 1791-1800

  Savic, Daniel ^a   Roberts, Brian S ^a   Carleton, Julia B ^b   Partridge, E Christopher ^a   White, Michæl A ^c   Cohen, Barak A ^c   Cooper, Gregory M ^a   Gertz, Jason ^b   Myers, Richard M ^a  

^a HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; HISTONE H3; PROMOTER DISTAL RNA POLYMERASE II; RNA POLYMERASE II; UNCLASSIFIED DRUG; HISTONE; PROTEIN BINDING;

3' UNTRANSLATED REGION; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA SEQUENCE; ENHANCER REGION; GENE CONTROL; HEPG2 CELL LINE; HUMAN; HUMAN CELL; K562 CELL LINE; LIVER CELL CARCINOMA; NEXT GENERATION SEQUENCING; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; ANTIBODY SPECIFICITY; BINDING SITE; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENETICS; HEP-G2 CELL LINE; K-562 CELL LINE; METABOLISM;

BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; HEP G2 CELLS; HISTONES; HUMANS; K562 CELLS; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RESPONSE ELEMENTS; RNA POLYMERASE II; SEQUENCE ANALYSIS, DNA;

EID: 84956624079     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.191593.115     Document Type: Article

References (47)

1. Bailey TL. 2011. DREME: motif discovery in transcription factor ChIP-seq data. Bioinformatics 27: 1653-1659.
2. Bulger M, Groudine M. 2011. Functional and mechanistic diversity of distal transcription enhancers. Cell 144: 327-339.
3. Cheng Y, Wu W, Kumar SA, Yu D, Deng W, Tripic T, King DC, Chen KB, Zhang Y, Drautz D, et al. 2009. Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res 19: 2172-2184.
4. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, JiangW, Marraffini LA, et al. 2013. Multiplex genome engineering using CRISPR/ Cas systems. Science 339: 819-823.
5. Core LJ, Martins AL, Danko CG, Waters CT, Siepel A, Lis JT. 2014. Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers. Nat Genet 46: 1311-1320.
6. De Santa F, Barozzi I, Mietton F, Ghisletti S, Polletti S, Tusi BK, Muller H, Ragoussis J, Wei CL, Natoli G. 2010. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol 8: e1000384.
7. DeLaForest A, Nagaoka M, Si-Tayeb K, Noto FK, Konopka G, Battle MA, Duncan SA. 2011. HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development 138: 4143-4153.
8. The ENCODE Project Consortium. 2007. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816.
9. The ENCODE Project Consortium. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57-74.
10. Ernst J, Kellis M. 2010. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol 28: 817-825.
11. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, WardLD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, et al. 2011. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473: 43-49.
12. Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB, Orlov YL, Velkov S, Ho A, Mei PH, et al. 2009. An oestrogen-receptor-α-bound human chromatin interactome. Nature 462: 58-64.
13. Gertz J, Reddy TE, Varley KE, Garabedian MJ, Myers RM. 2012. Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res 22: 2153-2162.
14. Guilluy C, Zhang Z, Bhende PM, Sharek L, Wang L, Burridge K, Damania B. 2011. Latent KSHV infection increases the vascular permeability of human endothelial cells. Blood 118: 5344-5354.
15. Hah N, Murakami S, Nagari A, Danko CG, Kraus WL. 2013. Enhancer transcripts mark active estrogen receptor binding sites. Genome Res 23: 1210-1223.
16. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, et al. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311-318.
17. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, et al. 2009. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459: 108-112.
18. Hertz GZ, Hartzell GW III, Stormo GD. 1990. Identification of consensus patterns in unaligned DNA sequences known to be functionally related. Comput Appl Biosci 6: 81-92.
19. Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J. 2013. RNA-programmed genome editing in human cells. eLife 2: e00471.
20. Johnson DS, Mortazavi A, Myers RM, Wold B. 2007. Genome-wide mapping of in vivo protein-DNA interactions. Science 316: 1497-1502.
21. Kasowski M, Kyriazopoulou-Panagiotopoulou S, Grubert F, Zaugg JB, Kundaje A, LiuY, BoyleAP, Zhang QC, Zakharia F, SpacekDV, et al. 2013. Extensive variation in chromatin states across humans. Science 342: 750-752.
22. Kheradpour P, Ernst J, Melnikov A, Rogov P, Wang L, Zhang X, Alston J, Mikkelsen TS, Kellis M. 2013. Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assay. Genome Res 23: 800-811.
23. Kilpinen H, Waszak SM, Gschwind AR, Raghav SK, Witwicki RM, Orioli A, Migliavacca E, Wiederkehr M, Gutierrez-Arcelus M, Panousis NI, et al. 2013. Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcription. Science 342: 744-747.
24. Kwasnieski JC, Mogno I, Myers CA, Corbo JC, Cohen BA. 2012. Complex effects of nucleotide variants in a mammalian cis-regulatory element. Proc Natl Acad Sci 109: 19498-19503.
25. Kwasnieski JC, Fiore C, Chaudhari HG, Cohen BA. 2014. High-throughput functional testing of ENCODE segmentation predictions. Genome Res 24: 1595-1602.
26. Lam MT, Cho H, Lesch HP, Gosselin D, Heinz S, Tanaka-Oishi Y, Benner C, Kaikkonen MU, Kim AS, Kosaka M, et al. 2013. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 498: 511-515.
27. Lettice LA, Heaney SJ, Purdie LA, Li L, de Beer P, Oostra BA, Goode D, Elgar G, Hill RE, de Graaff E. 2003. A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet 12: 1725-1735.
28. Levine M. 2010. Transcriptional enhancers in animal development and evolution. Curr Biol 20: R754-763.
29. LiW, Notani D, Ma Q, Tanasa B, Nunez E, Chen AY, Merkurjev D, Zhang J, Ohgi K, Song X, et al. 2013. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 498: 516-520.
30. Liu F, Li D, Yu YY, Kang I, Cha MJ, Kim JY, Park C, Watson DK, Wang T, Choi K. 2015. Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2. EMBO Rep 16: 654-669.
31. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. 2013. RNA-guided human genome engineering via Cas9. Science 339: 823-826.
32. Marden JJ, Zhang Y, Oakley FD, Zhou W, Luo M, Jia HP, McCray PB Jr, Yaniv M, Weitzman JB, Engelhardt JF. 2008. JunD protects the liver from ischemia/ reperfusion injury by dampening AP-1 transcriptional activation. J Biol Chem 283: 6687-6695.
33. McVicker G, van de Geijn B, Degner JF, Cain CE, Banovich NE, Raj A, Lewellen N, Myrthil M, Gilad Y, Pritchard JK. 2013. Identification of genetic variants that affect histone modifications in human cells. Science 342: 747-749.
34. Mouse ENCODE Consortium, Stamatoyannopoulos JA, Snyder M, Hardison R, Ren B, Gingeras T, Gilbert DM, Groudine M, Bender M, Kaul R, Canfield T, et al. 2012. An encyclopedia of mouse DNA elements (Mouse ENCODE). Genome Biol 13: 418.
35. Patwardhan RP, Hiatt JB, Witten DM, Kim MJ, Smith RP, May D, Lee C, Andrie JM, Lee SI, Cooper GM, et al. 2012. Massively parallel functional dissection of mammalian enhancers in vivo. Nat Biotechnol 30: 265-270.
36. Ramji DP, Foka P. 2002. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365(Pt 3): 561-575.
37. Reddy TE, Pauli F, Sprouse RO, Neff NF, Newberry KM, Garabedian MJ, Myers RM. 2009. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res 19: 2163-2171.
38. Sakabe NJ, Savic D, Nobrega MA. 2012. Transcriptional enhancers in development and disease. Genome Biol 13: 238.
39. Savic D, Gertz J, Jain P, Cooper GM, Myers RM. 2013. Mapping genomewide transcription factor binding sites in frozen tissues. Epigenetics Chromatin 6: 30.
40. Stepniak E, Ricci R, Eferl R, Sumara G, Sumara I, Rath M, Hui L, Wagner EF. 2006. c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev 20: 2306-2314.
41. Su M, Han D, Boyd-Kirkup J, Yu X, Han JD. 2014. Evolution of Alu elements toward enhancers. Cell Rep 7: 376-385.
42. Tjian R, Maniatis T. 1994. Transcriptional activation: a complex puzzle with few easy pieces. Cell 77: 5-8.
43. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, Chen F, et al. 2009. ChIP-seq accurately predicts tissuespecific activity of enhancers. Nature 457: 854-858.
44. White MA, Myers CA, Corbo JC, Cohen BA. 2013. Massively parallel in vivo enhancer assay reveals that highly local features determine the cis-regulatory function of ChIP-seq peaks. Proc Natl Acad Sci 110: 11952-11957.
45. Yang ZF, Drumea K, Cormier J, Wang J, Zhu X, Rosmarin AG. 2011. GABP transcription factor is required for myeloid differentiation, in part, through its control of Gfi-1 expression. Blood 118: 2243-2253.
46. Yu S, Cui K, Jothi R, Zhao DM, Jing X, Zhao K, Xue HH. 2011. GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem/progenitor cells. Blood 117: 2166-2178.
47. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, LiW, et al. 2008. Model-based analysis of ChIPSeq (MACS). Genome Biol 9: R137.